Compressed orally disintegrating tablets: excipients evolution and formulation strategies

被引:59
|
作者
Al-khattawi, Ali [1 ]
Mohammed, Afzal R. [1 ]
机构
[1] Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, W Midlands, England
关键词
compression; co-processing; mannitol; microcrystalline cellulose; orally disintegrating tablet; particle engineering; swallowing difficulty; MICROCRYSTALLINE CELLULOSE; DOSAGE FORM; MANNITOL; TRANSITION; STARCH; CROSPOVIDONE; PERFORMANCE; MEDICATION; DYSPHAGIA; MIXTURES;
D O I
10.1517/17425247.2013.769955
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Orally disintegrating tablets (ODTs) have emerged as one of the novel solid oral dosage forms with a potential to deliver a wide range of drug candidates to both paediatric and geriatric patient populations. Of the plethora of available technologies, compression of excipients offers a cost-effective and translatable methodology for the manufacture of ODTs. Areas covered: The review is a modest endeavour from the authors to assemble literature published over the last couple of decades on formulation development of compressed ODT. It describes the main ODT excipients used since the introduction of this dosage form in the 1990s and explores the switch from cellulose-based excipients towards sugar/polyols. Furthermore, it unfolds the key properties of ODT fillers, binders and disintegrants with an emphasis on their advantages and drawbacks. The review also provides a critical assessment of the various strategies employed for performance enhancement of compressed ODT with a focus on the underlying mechanisms for fast disintegration and acceptable mechanical strength. Expert opinion: Recent increase in the total number of compression-based technologies for ODT development promises to reduce the manufacturing cost of this dosage form in the future. However, some of the developed methods may affect the stability of tablets due to susceptibility to moisture, collapse of pores or the generation of less stable polymorphs which require rigorous testing prior to commercialization.
引用
收藏
页码:651 / 663
页数:13
相关论文
共 50 条
  • [1] Effect of excipients on the performance of orally disintegrating tablets
    Grachet, M.
    Morris, V.
    Bajwa, G.
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1327 - 1328
  • [2] Formulation technologies of orally fast disintegrating tablets
    Bircan, Yagmur
    Comoglu, Tansel
    [J]. MARMARA PHARMACEUTICAL JOURNAL, 2012, 16 (02) : 77 - 81
  • [3] Formulation and evaluation of orally disintegrating clopidogrel tablets
    Mahrous, Gamal Mohamed
    Kassem, Mohamed Gabr
    Ibrahim, Mohamed Abbas
    Auda, Sayed Hassan
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 52 (02) : 309 - 317
  • [4] Formulation studies for mirtazapine orally disintegrating tablets
    Yildiz, Simay
    Aytekin, Eren
    Yavuz, Burcin
    Pehlivan, Sibel Bozdag
    Unlu, Nursen
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (06) : 1008 - 1017
  • [5] Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs)
    Krzysztof Woyna-Orlewicz
    Witold Brniak
    Wiktor Tatara
    Magdalena Strzebońska
    Dorota Haznar-Garbacz
    Joanna Szafraniec-Szczęsny
    Agata Antosik-Rogóż
    Kamil Wojteczko
    Mirosław Strózik
    Mateusz Kurek
    Renata Jachowicz
    Aleksander Mendyk
    [J]. Pharmaceutical Research, 2023, 40 : 2947 - 2962
  • [6] Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs)
    Woyna-Orlewicz, Krzysztof
    Brniak, Witold
    Tatara, Wiktor
    Strzebonska, Magdalena
    Haznar-Garbacz, Dorota
    Szafraniec-Szczesny, Joanna
    Antosik-Rogoz, Agata
    Wojteczko, Kamil
    Strozik, Miroslaw
    Kurek, Mateusz
    Jachowicz, Renata
    Mendyk, Aleksander
    [J]. PHARMACEUTICAL RESEARCH, 2023, 40 (12) : 2947 - 2962
  • [7] Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
    Chono, Sumio
    Matsui, Megumi
    Nakamura, Katsuki
    Kasai, Ryoya
    [J]. JOURNAL OF PHARMACEUTICS, 2016, 2016
  • [8] Formulation of multiparticulate systems as lyophilised orally disintegrating tablets
    AlHusban, Farhan
    Perrie, Yvonne
    Mohammed, Afzal R.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 79 (03) : 627 - 634
  • [9] FORMULATION AND EVALUATION OF MECLIZINE HCl ORALLY DISINTEGRATING TABLETS
    Mahrous, Gamal M.
    Shazly, Gamal A.
    Ibrahim, Mohamed A.
    [J]. BULLETIN OF PHARMACEUTICAL SCIENCES, 2011, 34 : 141 - 148
  • [10] Formulation and development of paediatric orally disintegrating carbamazepine tablets
    Canadell-Heredia, R.
    Sune-Pou, M.
    Nardi-Ricart, A.
    Perez-Lozano, P.
    Sune-Negre, J. M.
    Garcia-Montoya, E.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (11) : 1612 - 1622